Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)
NCT00790946
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Obesity
Interventions
DRUG:
Valsartan
Sponsor
Kagoshima University